| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 1,390,716 | 1,455,169 | 1,505,296 | 2,082,284 | | Cost of Revenue | 893,008 | 1,001,011 | 979,579 | 1,533,673 | | | Gross Profit | 497,708 | 454,158 | 525,717 | 548,611 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 416,085 | 410,657 | 428,784 | 499,185 | | Non Recurring | 657 | (589) | (68) | 178,634 | | Others | 66,135 | 66,391 | 65,524 | 72,074 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,831 | (22,301) | 31,477 | (201,282) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 773 |
-
|
-
| (9,335) | | Earnings Before Interest And Taxes | 15,604 | (22,301) | 31,477 | (210,617) | | Interest Expense | 18,357 | 19,011 | 18,408 | 12,347 | | Income Before Tax | (2,753) | (41,312) | 13,069 | (222,964) | | Income Tax Expense | (12,560) | (15,040) | 4,650 | (75,970) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,011 | (26,657) | 7,663 | (149,348) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,011 | (26,657) | 7,663 | (149,348) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,011 | ($26,657) | $7,663 | ($149,348) |
|
0.11% Nasdaq 
0.29%
Income Statement
